Meeting of the Advisory Committee on Childhood Vaccines, 7402-7403 [2021-01879]

Download as PDF 7402 Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments on the collection(s) of information must be received by the OMB desk officer by March 1, 2021. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at website address at https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing.html. 2. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires federal agencies to publish a 30-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice that summarizes the following proposed collection(s) of information for public comment: 1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Disclosure Requirement for the In-Office Ancillary Services Exception; Use: Section 6003 of the Affordable Care Act (ACA) established a new disclosure requirement that a physician must perform for certain imaging services to meet the in-office ancillary services VerDate Sep<11>2014 17:16 Jan 27, 2021 Jkt 253001 exception to the prohibition of the physician self-referral law. This section of the ACA amended section 1877(b)(2) of the Act by adding a requirement that the referring physician informs the patient, at the time of the referral and in writing, that the patient may receive the imaging service from another supplier. Physicians who provide certain imaging services (MRI, CT, and PET) under the in-office ancillary services exception to the physician self-referral prohibition are required to provide the disclosure notice as well as the list of other imaging suppliers to the patient. The patient will then be able to use the disclosure notice and list of suppliers in making an informed decision about his or her course of care for the imaging service. CMS would use the collected information for enforcement purposes. Specifically, if we were investigating the referrals of a physician providing advanced imaging services under the inoffice ancillary services exception, we would review the written disclosure in order to determine if it satisfied the requirement. Form Number: CMS– 10332 (OMB control number: 0938– 1133); Frequency: Occasionally; Affected Public: Private Sector, Business or other for-profits, Not-for-profits institutions; Number of Respondents: 2,239; Total Annual Responses: 989,971; Total Annual Hours: 18,694. (For questions regarding this collection contact Laura Dash at 410–786–8623.) Dated: January 25, 2021. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2021–01896 Filed 1–27–21; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Committee on Childhood Vaccines Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Childhood Vaccines (ACCV) will hold public meetings for the 2021 calendar year (CY). Information about the ACCV, agendas, and materials for these meetings can be SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 found on the ACCV website at https:// www.hrsa.gov/advisory-committees/ vaccines. ACCV meetings will be held on: • March 4, 2021, 10:00 a.m. Eastern Time (ET)–4:00 p.m. ET; • June 3, 2021, 10:00 a.m. ET–4:00 p.m. ET; • September 2, 2021, 10:00 a.m. ET– 4:00 p.m. ET; • December 2, 2021, 10:00 a.m. ET– 4:00 p.m. ET. ADDRESSES: Meetings may be held inperson or by teleconference and webinar. For updates on how the meeting will be held, visit the ACCV website 30 business days before the date of the meeting, where instructions for joining meetings either in-person and remotely will also be posted. In-person ACCV meetings will be held at 5600 Fishers Lane, Rockville, Maryland 20857. For meeting information updates, go to the ACCV website listed above. FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; 301–443–6634; or ACCV@ HRSA.gov. DATES: The ACCV provides advice and recommendations to the Secretary of HHS on policy, program development, and other issues related to implementation of the National Vaccine Injury Compensation Program (VICP) and concerning other matters as described under section 2119 of the Public Health Service Act (42 U.S.C. 300aa–19). Since priorities dictate meeting times, be advised that times and agenda items are subject to change. Refer to the ACCV website listed above for any meeting updates that may occur. For CY 2021 meetings, agenda items may include, but are not limited to updates from the Division of Injury Compensation Programs, Department of Justice, Office of Infectious Disease and HIV/AIDS Policy (HHS), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics, Evaluation and Research (Food and Drug Administration). Refer to the ACCV website listed above for all current and updated information concerning the CY 2021 ACCV meetings, including draft agendas and meeting materials that will be posted 5 calendar days before the meeting(s). Members of the public will have the opportunity to provide comments. SUPPLEMENTARY INFORMATION: E:\FR\FM\28JAN1.SGM 28JAN1 Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices Public participants may submit written statements in advance of the scheduled meeting(s). Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to ACCV should be sent to Annie Herzog using the contact information above at least 5 business days before the meeting date(s). Individuals who need special assistance or another reasonable accommodation should notify Annie Herzog using the contact information listed above at least 10 business days before the meeting(s) they wish to attend. If an in-person meeting is held, it will occur in a federal government building and all attendees must go through a security check to enter. Non-U.S. Citizen attendees must notify HRSA of their planned attendance to an inperson meeting at least 20 business days prior to the meeting in order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–01879 Filed 1–27–21; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF THE INTERIOR National Park Service [NPS–WASO–NAGPRA–NPS0031389; PPWOCRADN0–PCU00RP14.R50000] Notice of Intent To Repatriate Cultural Items: Geneva Historical Society, Geneva, NY National Park Service, Interior. Notice. AGENCY: ACTION: The Geneva Historical Society, in consultation with the appropriate Indian Tribes or Native Hawaiian organizations, has determined that one cultural item listed in this notice meets the definition of unassociated funerary object and 103 cultural items listed in this notice meet the definition of objects of cultural patrimony. Lineal descendants or representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to claim these cultural items should submit a written request to the Geneva Historical Society. If no additional claimants come forward, transfer of control of the cultural items to the lineal descendants, Indian Tribes, or Native SUMMARY: VerDate Sep<11>2014 17:16 Jan 27, 2021 Jkt 253001 7403 Hawaiian organizations stated in this notice may proceed. DATES: Lineal descendants or representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to claim these cultural items should submit a written request with information in support of the claim to the Geneva Historical Society at the address in this notice by March 1, 2021. ADDRESSES: Kerry Lippincott, Geneva Historical Society, 543 South Main Street, Geneva, NY 14456, telephone (315) 789–5151, email director@ genevahistoricalsociety.com. SUPPLEMENTARY INFORMATION: Notice is here given in accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), 25 U.S.C. 3005, of the intent to repatriate cultural items under the control of the Geneva Historical Society, Geneva, NY, that meet the definition of unassociated funerary objects and objects of cultural patrimony under 25 U.S.C. 3001. This notice is published as part of the National Park Service’s administrative responsibilities under NAGPRA, 25 U.S.C. 3003(d)(3). The determinations in this notice are the sole responsibility of the museum, institution, or Federal agency that has control of the Native American cultural items. The National Park Service is not responsible for the determinations in this notice. of Indians identified the hair comb as a funerary object. Given the location and time period, the other items are consistent with Seneca production and European trade goods. History and Description of the Cultural Items In the mid-1800s, 104 cultural items were removed from White Springs Farm, Ontario County, NY. According to printed accounts, two burial mounds near the farm’s manor house were disturbed around 1840, when the land was graded for a lawn and roadway. The artifacts stayed with the farm and were transferred to subsequent owners until Mrs. Katherine Lewis purchased the property in 1898. Lewis kept the artifacts in her family. In 1962, her daughter, Mrs. Henry Wheat, loaned them to the Geneva Historical Society, and in 1978, the Wheats converted the loan to a gift. The one unassociated funerary object is a wooden hair comb. The 103 objects of cultural patrimony are 90 assorted beads of bloodstone, glass, shell, bone, and clay; one rifle trigger; two metal trade arrowheads; two metal fragments; three metal buttons; four 17th-century religious trade medals; and one clay pipe. There is archeological evidence to show that from around 1688 to 1715, the Seneca town of Ganechstage was located in proximity to White Springs Farm. During consultation, the Seneca Nation Additional Requestors and Disposition PO 00000 Frm 00051 Fmt 4703 Sfmt 9990 Determinations Made by the Geneva Historical Society Officials of the Geneva Historical Society have determined that: • Pursuant to 25 U.S.C. 3001(3)(B), the one cultural item described above is reasonably believed to have been placed with or near individual human remains at the time of death or later as part of the death rite or ceremony and are believed, by a preponderance of the evidence, to have been removed from a specific burial site of a Native American individual. • Pursuant to 25 U.S.C. 3001(3)(D), the 103 cultural items described above have ongoing historical, traditional, or cultural importance central to the Native American group or culture itself, rather than property owned by an individual. • Pursuant to 25 U.S.C. 3001(2), there is a relationship of shared group identity that can be reasonably traced between the unassociated funerary object, and objects of cultural patrimony and the Seneca Nation of Indians (previously listed as Seneca Nation of New York). Lineal descendants or representatives of any Indian Tribe or Native Hawaiian organization not identified in this notice that wish to claim these cultural items should submit a written request with information in support of the claim to Kerry Lippincott, Geneva Historical Society, 543 South Main Street, Geneva, NY 14456, telephone (315) 789–5151, email director@ genevahistoricalsociety.com, by March 1, 2021. After that date, if no additional claimants have come forward, transfer of control of the unassociated funerary object and objects of cultural patrimony to the Seneca Nation of Indians (previously listed as Seneca Nation of New York) may proceed. The Geneva Historical Society is responsible for notifying the Seneca Nation of Indians (previously listed as Seneca Nation of New York) that this notice has been published. Dated: January 14, 2021. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2021–01899 Filed 1–27–21; 8:45 am] BILLING CODE 4312–52–P E:\FR\FM\28JAN1.SGM 28JAN1

Agencies

[Federal Register Volume 86, Number 17 (Thursday, January 28, 2021)]
[Notices]
[Pages 7402-7403]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01879]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Childhood Vaccines 
(ACCV) will hold public meetings for the 2021 calendar year (CY). 
Information about the ACCV, agendas, and materials for these meetings 
can be found on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines.

DATES: ACCV meetings will be held on:
     March 4, 2021, 10:00 a.m. Eastern Time (ET)-4:00 p.m. ET;
     June 3, 2021, 10:00 a.m. ET-4:00 p.m. ET;
     September 2, 2021, 10:00 a.m. ET-4:00 p.m. ET;
     December 2, 2021, 10:00 a.m. ET-4:00 p.m. ET.

ADDRESSES: Meetings may be held in-person or by teleconference and 
webinar. For updates on how the meeting will be held, visit the ACCV 
website 30 business days before the date of the meeting, where 
instructions for joining meetings either in-person and remotely will 
also be posted. In-person ACCV meetings will be held at 5600 Fishers 
Lane, Rockville, Maryland 20857. For meeting information updates, go to 
the ACCV website listed above.

FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury 
Compensation Programs, HRSA, 5600 Fishers Lane, Rockville, Maryland 
20857; 301-443-6634; or [email protected].

SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations 
to the Secretary of HHS on policy, program development, and other 
issues related to implementation of the National Vaccine Injury 
Compensation Program (VICP) and concerning other matters as described 
under section 2119 of the Public Health Service Act (42 U.S.C. 300aa-
19).
    Since priorities dictate meeting times, be advised that times and 
agenda items are subject to change. Refer to the ACCV website listed 
above for any meeting updates that may occur. For CY 2021 meetings, 
agenda items may include, but are not limited to updates from the 
Division of Injury Compensation Programs, Department of Justice, Office 
of Infectious Disease and HIV/AIDS Policy (HHS), Immunization Safety 
Office (Centers for Disease Control and Prevention), National Institute 
of Allergy and Infectious Diseases (National Institutes of Health) and 
Center for Biologics, Evaluation and Research (Food and Drug 
Administration). Refer to the ACCV website listed above for all current 
and updated information concerning the CY 2021 ACCV meetings, including 
draft agendas and meeting materials that will be posted 5 calendar days 
before the meeting(s).
    Members of the public will have the opportunity to provide 
comments.

[[Page 7403]]

Public participants may submit written statements in advance of the 
scheduled meeting(s). Oral comments will be honored in the order they 
are requested and may be limited as time allows. Requests to submit a 
written statement or make oral comments to ACCV should be sent to Annie 
Herzog using the contact information above at least 5 business days 
before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Annie Herzog using the contact information 
listed above at least 10 business days before the meeting(s) they wish 
to attend.
    If an in-person meeting is held, it will occur in a federal 
government building and all attendees must go through a security check 
to enter. Non-U.S. Citizen attendees must notify HRSA of their planned 
attendance to an in-person meeting at least 20 business days prior to 
the meeting in order to facilitate their entry into the building. All 
attendees are required to present government-issued identification 
prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-01879 Filed 1-27-21; 8:45 am]
BILLING CODE 4165-15-P